Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.

Stedman MPeter TaylorLakdasa D K E Premawardhana Onyebuchi E OkosiemeColin DayanAdrian H Heald

Published in: Clinical endocrinology (2021)

In spite of strenuous attempts to limit prescribing of liothyronine in general practice, a significant number of patients continue to receive this therapy. The price differential of liothyronine vs levothyroxine should be examined again in light of the continuing use of liothyronine.

Keyphrases

general practice
primary care
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
adverse drug
emergency department
mesenchymal stem cells
cell therapy
replacement therapy